Allogene Therapeutics, Inc.
NASDAQ:ALLO
1.57 (USD) • At close April 28, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -257.59 | -327.265 | -332.632 | -257.005 | -250.221 | -184.594 | -211.505 | -0.024 |
| Depreciation & Amortization
| 13.639 | 14.199 | 14.295 | 10.454 | 7.586 | 5.027 | 1.5 | 0 |
| Deferred Income Tax
| 0 | 0 | 8.079 | 10.399 | 4.404 | -0.331 | -0.117 | 0 |
| Stock Based Compensation
| 51.743 | 65.951 | 83.6 | 80.818 | 65.261 | 46.063 | 18.566 | 0 |
| Change In Working Capital
| -24.799 | -15.305 | 3.706 | -32.089 | 53.922 | -6.878 | 12.096 | 0.024 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.503 | -7.502 | 4.868 | -0.767 | 0.615 | -0.985 | 8.8 | 0 |
| Other Working Capital
| -24.296 | -7.803 | -1.162 | -31.322 | 53.307 | -5.893 | 3.296 | 0.024 |
| Other Non Cash Items
| 16.707 | 24.687 | 2.433 | 2.611 | 3.955 | 3.363 | 134.807 | 0 |
| Operating Cash Flow
| -200.3 | -237.733 | -220.519 | -184.812 | -115.093 | -137.35 | -44.653 | 0 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -0.694 | -1.516 | -5.191 | -21.446 | -65.958 | -50.791 | -3.234 | 0 |
| Acquisitions Net
| 0 | 0 | -111.35 | -17.71 | 439.165 | -5.075 | 0 | 0 |
| Purchases Of Investments
| -361.475 | -438.629 | -248.109 | -525.583 | -1,037.591 | -252.628 | -649.307 | 0 |
| Sales Maturities Of Investments
| 437.857 | 603.434 | 359.459 | 728.394 | 598.426 | 472.578 | 21.841 | 0 |
| Other Investing Activites
| 0 | 0 | 111.35 | 185.101 | -439.165 | 214.875 | -2.098 | 0 |
| Investing Cash Flow
| 75.688 | 163.289 | 106.159 | 163.655 | -505.123 | 164.084 | -632.798 | 0 |
| Financing Activities: | ||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 116.842 | 0 |
| Common Stock Issued
| 112.047 | 91.112 | 2.95 | 11.963 | 621.933 | 54.219 | 343.689 | 0 |
| Common Stock Repurchased
| 1.535 | 0 | 2.461 | 3.617 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 4.628 | 4.583 | 2.95 | 11.963 | 11.658 | 4.741 | 953.621 | 0 |
| Financing Cash Flow
| 116.675 | 95.695 | 2.95 | 11.963 | 633.591 | 58.96 | 771.182 | 0 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -7.937 | 21.251 | -111.41 | -9.194 | 13.375 | 85.694 | 93.731 | 0 |
| Cash At End Of Period
| 85.51 | 93.447 | 72.196 | 183.606 | 192.8 | 179.425 | 93.731 | 0 |